ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
유전학적 검사 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.0%로 93억 5,000만 달러에 달할 전망입니다. 예측 기간 동안 예상되는 성장은 공공 및 민간의 유전체 관련 이니셔티브 간의 협력 확대, 비침습적 산전검사(NIPT)에 대한 수요 증가, 유전자 검사 패널 및 키트 유형 증가, 집단 전체 검진 프로그램에서의 사용 확대, 예방적이고 정밀한 공중보건에 대한 집중 강화 등에 기인합니다. 것으로 예측됩니다. 이 기간의 주요 동향으로는 차세대 염기서열 분석(NGS)의 발전, NIPT의 기술 혁신, 바이오인포매틱스 플랫폼의 발전, 포인트 오브 케어 유전자 검사 장비의 개선, 다유전자 패널 검사 개발 등이 있습니다.
유전성 질환의 유병률 증가는 향후 유전학적 검사 시장의 성장을 가속할 것으로 예측됩니다. 유전성 질환은 개인의 데옥시리보핵산(DNA)의 이상이나 돌연변이로 인해 발생하는 병으로, 한쪽 부모로부터 물려받거나 자연적으로 발생합니다. 유전성 질환 증가는 부모의 연령이 높아지면서 유전자의 돌연변이가 자손에게 유전될 가능성이 높아진 것이 한 요인으로 작용하고 있습니다. 유전학적 검사는 유전적 돌연변이 식별을 통해 조기 진단을 가능하게 하고, 개인별 맞춤 치료를 유도하며, 가족계획 결정을 지원함으로써 유전성 질환 환자들을 돕습니다. 예를 들어, 2024년 10월 영국에 기반을 둔 자선단체인 낭포성 섬유증 트러스트(Cystic Fibrosis Trust)는 낭포성 섬유증 등록 환자 수가 2022년 1만 1,148명에서 2023년 1만 1,318명으로 증가했다고 보고했습니다. 이처럼 유전성 질환의 유병률 증가는 유전학적 검사 시장에 박차를 가하고 있습니다.
유전자 검사 시장의 주요 기업들은 정확도 향상, 납기 단축, 보다 광범위한 유전자 변이 검출을 확대하기 위해 유전자 검사 키트의 기술 발전에 주력하고 있습니다. 유전자 검사 키트는 개인의 DNA를 분석하여 유전 질환 및 위험 요인과 관련된 돌연변이 및 변이를 식별하도록 설계된 진단 도구입니다. 예를 들어, 2023년 7월 스웨덴에 본사를 둔 유전성 질환 DNA 진단 키트 전문 생명공학 기업 Devyser Diagnostics AB는 두 가지 새로운 표적형 차세대 염기서열 분석 키트인 Devyser LynchFAP와 Devyser BRCA PALB2입니다. Devyser LynchFAP는 유전성 대장암 증후군과 관련된 PMS2(위유전자 PMS2CL의 문제 해결) 및 기타 9개의 주요 유전자를 종합적으로 분석할 수 있습니다. Devyser BRCA PALB2는 혈액 및 종양 샘플에서 BRCA1, BRCA2, PALB2 변이를 스크리닝하기 위한 간소화된 단일 튜브 솔루션으로, 유전성 암 위험을 확실하게 검출하기 위한 사용하기 쉬운 시퀀싱과 전용 소프트웨어로 효율적인 실험실 워크플로우를 지원하도록 설계되었습니다. 효율적인 실험실 워크플로우를 지원하도록 설계되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계 성장 분석과 전략 분석 프레임워크
세계의 유전학적 검사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 유전학적 검사 시장 : 성장률 분석
세계의 유전학적 검사 시장 실적 : 규모와 성장, 2019-2024년
세계의 유전학적 검사 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 유전학적 검사 : 전체 시장(TAM)
제6장 시장 세분화
세계의 유전학적 검사 시장 : 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
예측 검사
보인자 검사
산전 검사
신생아 스크리닝
진단 검사
기타
세계의 유전학적 검사 시장 : 샘플 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
혈액 샘플
타액 샘플
조직 샘플
구강 내막 면봉
소변 샘플
세계의 유전학적 검사 시장 : 사용되는 기술별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
차세대 시퀀싱(NGS)
중합효소 연쇄반응(PCR)
생어-시퀀싱
마이크로어레이 기술
전장 유전체 시퀀싱(WGS)
세계의 유전학적 검사 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
종양학
심혈관질환
신경질환
대사장애
기타
세계의 유전학적 검사 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
진단실험실
연구기관
제약회사
환자 및 소비자
세계의 유전학적 검사 시장 : 예측 검사별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
유방암 1형(BRCA1)/유방암 2형(BRCA2) 유전자 변이 검사
린치 증후군 검사
가족성 고콜레스테롤혈증 검사
헌팅턴병 검사
심근증 유전자 검사
세계의 유전학적 검사 시장 : 캐리어 검사별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
낭포성 섬유증 보인자 검사
테이-삭스병 보인자 검사
척추근육위축증(SMA) 보인자 검사
지중해빈혈 보인자 검사
겸상적혈구병 보인자 검사
세계의 유전학적 검사 시장 : 산전 검사별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
비침습적 산전 검사(NIPT)
융모막 융모 채취(CVS)
양수천자
확대 캐리어 스크리닝(산전)
유리 태아 디옥시리보핵산 검사
세계의 유전학적 검사 시장 : 신생아 스크리닝별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
페닐케톤뇨증(PKU) 스크리닝
선천성 갑상선 기능 저하증 스크리닝
낭포성 섬유증 스크리닝
겸상 적혈구증 스크리닝
난청 및 대사장애에 관한 패널
세계의 유전학적 검사 시장 : 진단 검사별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
희귀질환 유전자 검사
유전성 암 진단 검사
심장 발생 진단 패널
신경 유전성 질환 검사
단일 유전자 질환 패널
세계의 유전학적 검사 시장 : 기타별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
약물유전체학 검사
착상 전 유전자 진단(PGD)
전체 엑솜 시퀀싱(WES)
전체 게놈 시퀀싱(WGS)
미토콘드리아 DNA 검사
제7장 지역별/국가별 분석
세계의 유전학적 검사 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 유전학적 검사 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
유전학적 검사 시장 : 경쟁 구도
유전학적 검사 시장 : 기업 개요
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
Quest Diagnostics Incorporated
Agilent Technologies Inc.
제31장 기타 주요 기업 및 혁신 기업
Illumina Inc.
CooperSurgical Inc.
QIAGEN N.V
Natera Inc.
Myriad Genetics Inc.
Fulgent Genetics Inc
Invitae Corporation
GeneDx LLC
Twist Bioscience Corporation
Color Health Inc.
MedGenome Inc
SOPHiA GENETICS SA
Gene By Gene Ltd.
Dante Labs Inc.
23mofang Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 전략
유전학적 검사 시장, 2029년 : 새로운 기회를 제공하는 국가
유전학적 검사 시장, 2029년 : 새로운 기회를 제공하는 부문
유전학적 검사 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Hereditary testing, also known as genetic testing for inherited conditions, involves analyzing an individual's DNA to detect genetic mutations or variations inherited from their parents. These tests help evaluate the risk of developing or passing on inherited diseases, assist in diagnosing genetic disorders, and support personalized treatment or preventive care decisions.
The primary types of hereditary testing include predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic testing, and others. Predictive testing is used to determine the likelihood that an individual will develop a particular disease or condition in the future, before symptoms arise. Sample types for these tests include blood, saliva, tissue, buccal swabs, and urine. The technologies employed range from next-generation sequencing (NGS), polymerase chain reaction (PCR), Sanger sequencing, microarray technology, to whole genome sequencing (WGS). These tests are applied in various fields such as oncology, cardiovascular diseases, neurological disorders, metabolic disorders, and more, and are utilized by a wide range of end users including hospitals, diagnostic labs, research institutions, pharmaceutical companies, patients, and consumers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The hereditary testing market research report is one of a series of new reports from The Business Research Company that provides hereditary testing market statistics, including hereditary testing industry global market size, regional shares, competitors with a hereditary testing market share, detailed hereditary testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary testing industry. The hereditary testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hereditary testing market size has grown strongly in recent years. It will grow from $6.05 billion in 2024 to $6.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be credited to increasing parental age, broader use in cancer risk assessment, heightened demand for early diagnosis and prevention, a rising burden of rare and chronic diseases, improved access to genetic counseling services, and greater adoption of hereditary testing in reproductive health.
The hereditary testing market size is expected to see strong growth in the next few years. It will grow to $9.35 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The anticipated growth in the forecast period can be attributed to expanding collaborations between public and private genomic initiatives, rising demand for non-invasive prenatal testing (NIPT), an increasing variety of genetic testing panels and kits, greater use in population-wide screening programs, and a stronger focus on preventive and precision public health. Key trends during this period include advancements in next-generation sequencing (NGS), technological innovations in NIPT, progress in bioinformatics platforms, improvements in point-of-care genetic testing devices, and developments in multi-gene panel testing.
The rising prevalence of genetic disorders is expected to drive the growth of the hereditary testing market in the future. Genetic disorders are medical conditions caused by abnormalities or mutations in an individual's deoxyribonucleic acid (DNA), inherited from one or both parents or occurring spontaneously. The increase in genetic disorders is partly due to higher parental age, which raises the chances of passing genetic mutations to offspring. Hereditary testing aids patients with genetic disorders by enabling early diagnosis, guiding personalized treatments, and assisting family planning decisions through the identification of inherited mutations. For example, in October 2024, the Cystic Fibrosis Trust, a UK-based charity, reported that the number of registered cystic fibrosis patients increased to 11,318 in 2023, up from 11,148 in 2022. Thus, the growing prevalence of genetic disorders is fueling the hereditary testing market.
Key players in the hereditary testing market are focusing on technological advancements in genetic test kits to improve accuracy, shorten turnaround times, and expand the detection of a wider range of genetic mutations. Genetic test kits are diagnostic tools designed to analyze an individual's DNA to identify mutations or variations linked to inherited diseases or risk factors. For instance, in July 2023, Devyser Diagnostics AB, a Sweden-based biotech company specializing in DNA diagnostic kits for hereditary diseases, launched two new targeted next-generation sequencing kits: Devyser LynchFAP and Devyser BRCA PALB2. Devyser LynchFAP allows comprehensive analysis of PMS2 (addressing challenges from its pseudogene PMS2CL) along with nine other key genes associated with hereditary colorectal cancer syndromes. Devyser BRCA PALB2 provides a streamlined single-tube solution for screening BRCA1, BRCA2, and PALB2 mutations in both blood and tumor samples, designed to support efficient lab workflows with user-friendly sequencing and dedicated software for confident detection of hereditary cancer risks.
In May 2025, GeneDx LLC, a US-based biotechnology firm specializing in genetic testing, acquired Fabric Genomics for an undisclosed sum. This acquisition aims to enhance GeneDx's genomic interpretation capabilities by integrating Fabric Genomics' AI-powered platform, thereby strengthening its hereditary disease diagnostic offerings and enabling faster, more scalable genetic analysis. Fabric Genomics is a US-based computational genomics company providing hereditary testing solutions.
Major players in the hereditary testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., CooperSurgical Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, GeneDx LLC, Twist Bioscience Corporation, Color Health Inc., MedGenome Inc, SOPHiA GENETICS SA, Gene By Gene Ltd., Dante Labs Inc., 23mofang Co. Ltd.
North America was the largest region in the hereditary testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hereditary testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the hereditary testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The hereditary testing market includes revenues earned by entities through services such as genetic screening, pharmacogenetic testing, and presymptomatic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hereditary Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hereditary testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for hereditary testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hereditary testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Test Type: Predictive Testing; Carrier Testing; Prenatal Testing; Newborn Screening; Diagnostic Testing; Other Test Types
4) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Metabolic Disorders; Other Applications
5) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Patients And Consumers
Subsegments:
1) By Predictive Testing: Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Gene Mutation Testing; Lynch Syndrome Testing; Familial Hypercholesterolemia Testing; Huntington's Disease Testing; Cardiomyopathy Genetic Testing
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Hereditary Testing Market Characteristics
3. Hereditary Testing Market Trends And Strategies
4. Hereditary Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Hereditary Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Hereditary Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Hereditary Testing Market Growth Rate Analysis
5.4. Global Hereditary Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Hereditary Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Hereditary Testing Total Addressable Market (TAM)
6. Hereditary Testing Market Segmentation
6.1. Global Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Predictive Testing
Carrier Testing
Prenatal Testing
Newborn Screening
Diagnostic Testing
Other Test Types
6.2. Global Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Samples
Saliva Samples
Tissue Samples
Buccal Swabs
Urine Samples
6.3. Global Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Sanger Sequencing
Microarray Technology
Whole Genome Sequencing (WGS)
6.4. Global Hereditary Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Cardiovascular Diseases
Neurological Disorders
Metabolic Disorders
Other Applications
6.5. Global Hereditary Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Laboratories
Research Institutes
Pharmaceutical Companies
Patients And Consumers
6.6. Global Hereditary Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breast Cancer 1 (BRCA1) And Breast Cancer 2 (BRCA2) Gene Mutation Testing
Lynch Syndrome Testing
Familial Hypercholesterolemia Testing
Huntington's Disease Testing
Cardiomyopathy Genetic Testing
6.7. Global Hereditary Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cystic Fibrosis Carrier Screening
Tay-Sachs Carrier Screening
Spinal Muscular Atrophy (SMA) Carrier Screening
Thalassemia Carrier Screening
Sickle Cell Carrier Testing
6.8. Global Hereditary Testing Market, Sub-Segmentation Of Prenatal Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Invasive Prenatal Testing (NIPT)
Chorionic Villus Sampling (CVS)
Amniocentesis
Expanded Carrier Screening (Prenatal Context)
Cell-Free Fetal Deoxyribonucleic Acid Testing
6.9. Global Hereditary Testing Market, Sub-Segmentation Of Newborn Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phenylketonuria (PKU) Screening
Congenital Hypothyroidism Screening
Cystic Fibrosis Screening
Sickle Cell Disease Screening
Hearing Loss And Metabolic Disorder Panels
6.10. Global Hereditary Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rare Disease Genetic Testing
Inherited Cancer Diagnostic Testing
Cardiogenetic Diagnostic Panels
Neurogenetic Disorder Testing
Monogenic Disease Panels
6.11. Global Hereditary Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmacogenomics Testing
Preimplantation Genetic Diagnosis (PGD)
Whole Exome Sequencing (WES)
Whole Genome Sequencing (WGS)
Mitochondrial Deoxyribonucleic Acid Testing
7. Hereditary Testing Market Regional And Country Analysis
7.1. Global Hereditary Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Hereditary Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
